Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Novo Not Discussing Further Pill Discounts, CEO Says

Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua. (Source: Bloomberg)

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

More from Wednesday 5 August →